Pulmonary Arterial Hypertension | Norton Healthcare

Indication: Pulmonary Arterial Hypertension

An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)

Sub-indication: Pulmonary Arterial Hypertension

Study Type: Drug Study

Principal Investigator: John McConnell, M.D.
Norton Pulmonary Specialists

Sponsor: Sponsor: Gossamer Bio, Inc.

Learn more at ClinicalTrials.gov

Email for more information: npsresearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.